These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 15147776
1. Effect of naloxone-precipitated morphine withdrawal on c-fos expression in rat corticotropin-releasing hormone neurons in the paraventricular hypothalamus and extended amygdala. Hamlin AS, Buller KM, Day TA, Osborne PB. Neurosci Lett; 2004 May 13; 362(1):39-43. PubMed ID: 15147776 [Abstract] [Full Text] [Related]
2. Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal. Nunez C, Földes A, Laorden ML, Milanes MV, Kovács KJ. J Neurochem; 2007 May 13; 101(4):1060-71. PubMed ID: 17286593 [Abstract] [Full Text] [Related]
6. Dissection of peripheral and central endogenous opioid modulation of systemic interleukin-1beta responses using c-fos expression in the rat brain. Buller KM, Hamlin AS, Osborne PB. Neuropharmacology; 2005 Aug 13; 49(2):230-42. PubMed ID: 15993445 [Abstract] [Full Text] [Related]
7. Role of PKC-alpha,gamma isoforms in regulation of c-Fos and TH expression after naloxone-induced morphine withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups. Benavides M, Laorden ML, Marín MT, Milanés MV. J Neurochem; 2005 Dec 13; 95(5):1249-58. PubMed ID: 16190878 [Abstract] [Full Text] [Related]
10. Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus. Núñez C, González-Cuello A, Sánchez L, Vargas ML, Milanés MV, Laorden ML. Eur J Pharmacol; 2009 Oct 12; 620(1-3):1-8. PubMed ID: 19683523 [Abstract] [Full Text] [Related]
12. Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response. Milanés MV, Laorden ML, Chapleur-Château M, Burlet A. J Pharmacol Exp Ther; 1998 May 12; 285(2):700-6. PubMed ID: 9580616 [Abstract] [Full Text] [Related]
14. Corticotropin-releasing hormone heterogeneous nuclear RNA (hnRNA) and immunoreactivity are induced in extrahypothalamic brain sites by kainic-acid-induced seizures and are modulated by estrogen. Foradori CD, Lund TD, Nagahara AH, Koenig JI, Handa RJ. Brain Res; 2007 Aug 20; 1164():44-54. PubMed ID: 17631870 [Abstract] [Full Text] [Related]
15. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons. Spiga F, Lightman SL, Shekhar A, Lowry CA. Neuroscience; 2006 Aug 20; 138(4):1265-76. PubMed ID: 16488545 [Abstract] [Full Text] [Related]
16. Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal. Navarro-Zaragoza J, Núñez C, Laorden ML, Milanés MV. Mol Pharmacol; 2010 May 20; 77(5):864-73. PubMed ID: 20159948 [Abstract] [Full Text] [Related]
17. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Sakamoto F, Yamada S, Ueta Y. Regul Pept; 2004 May 15; 118(3):183-91. PubMed ID: 15003835 [Abstract] [Full Text] [Related]
20. Activation of c-fos expression in the heart after morphine but not U-50,488H withdrawal. González-Cuello A, Milanés MV, Castells MT, Laorden ML. Br J Pharmacol; 2003 Feb 15; 138(4):626-33. PubMed ID: 12598416 [Abstract] [Full Text] [Related] Page: [Next] [New Search]